by Jordana Choucair | Oct 11, 2022 | Opioid/Substance Use Disorders
A Kaiser Health News investigation found that many hospitals don’t have specialists who know how to treat addiction. While hospitals employ numerous clinicians – physicians, nurses, therapists, or social workers – who can support patients with heart, lung, or kidney...
by Jordana Choucair | Oct 11, 2022 | Payers
A New York Times (NYT) review of federal lawsuits and investigations found that insurers have been using lucrative strategies to get more money from Medicare Advantage (MA) program than they may legally be due. According to the review, eight of the 10 largest MA...
by Jordana Choucair | Oct 7, 2022 | Life Sciences
U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said the agency would “continue to explore every option we have” with regard to lowering drug prices. According to Becerra, even utilizing so-called march-in rights — power granted...
by Jordana Choucair | Oct 7, 2022 | Life Sciences
Center for Medicare Director Meena Seshamani said drugmakers who raise prices on medicines for patients with private insurance will still face penalties under the Inflation Reduction Act’s drug pricing law. If drugmakers increase prices faster than the rate of...
by Jordana Choucair | Oct 7, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) released Medicare Advantage (MA) plan star ratings, revealing the average rating for the private plans has fallen compared to last year. The average rating across all plans is 4.15 out of a possible 5 stars for...
Recent Comments